+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 6 Actively Recruiting clinical trials

E

Actively Recruiting

People with mental disorders often experience stigma from others and may internalize these negative attitudes, leading to self-stigma. This self-stigma can cause emotional distress such as shame and reduce coping skills, making social interaction and adherence to care more difficult. The study aims to evaluate the effectiveness and acceptability of group-based Compassion Focused Therapy CFT in reducing self-stigma, compared to treatment as usual and a psychoeducation program previously studied. The study compares three approaches Compassion Focused Therapy, which includes both psychoeducation and experiential exercises to foster self-compassion and reduce shame a psychoeducation program called Ending Self Stigma that helps participants modify self-stigmatizing thoughts and increase self-esteem and treatment as usual. The interventions involve sessions with practices such as guided imagery and writing exercises, with some activities provided online for home practice. Participants will be adults with chronic psychiatric or neurodevelopmental disorders who have moderate to high self-stigma. They will be assessed using the Internalized Stigma of Mental Illness inventory at baseline and monthly for three months. The study will monitor changes in self-stigma and other clinical aspects over the treatment period. Participation involves random assignment to one of the study groups, and safety and acceptability will be evaluated throughout the study, which is expected to run until 2028.

Age: 18Years +All GendersPhase Not Applicable
7 locations
E

Actively Recruiting

Researchers are evaluating a Mobile Perinatal Psychiatry Team EMPPer that supports children aged 0 to 3 years and their parents by providing psychiatric care directly to families facing difficulties. This approach aims to improve early detection and intervention for developmental and neurodevelopmental disorders, promoting better psychomotor development and child language outcomes. The study compares areas with and without EMPPer services and examines its impact on child development and healthcare costs. The intervention involves a mobile team visiting families in a designated region Meurthe-et-Moselle Sud to facilitate access to psychiatric care, especially for vulnerable populations. Children in this area receive the EMPPer intervention, while children in comparison regions Strasbourg and Reims do not. The study uses a quasi-experimental design including before-and-after comparisons and process evaluations to assess implementation, impact, and cost-effectiveness. Participants include children aged 0 to 3 years and their families. Data collection occurs at ages 2 and 4 years, including psychomotor development assessments, language delay evaluations, satisfaction and therapeutic alliance questionnaires, and healthcare cost analyses. The study uses observations, interviews, and standardized tools to understand the interventions effects and sustainability over time, with a total follow-up period extending to 4 years.

Age: 1Day - 3YearsAll GendersPhase Not Applicable
1 location
C

Actively Recruiting

Researchers are evaluating whether the EMOCARE emotional monitoring software provides consistent results compared to standard questionnaires used to assess emotional states in patients with mild to moderately severe depressive episodes. This study aims to understand how well EMOCARE matches tools like PHQ-9, MADRS, GAD-7, BDI-II, and EQ-5D-5L, and to learn about any medical issues participants may experience when using this passive monitoring software. The study focuses on outpatients with major depressive disorder who use digital devices regularly. Participants will install the EMOCARE software on a smartphone, computer, or similar device and can activate or deactivate it during a six-week follow-up period. They will attend two scheduled visits at the centerone at the start and one six weeks laterto complete questionnaires and be interviewed by a doctor. Additionally, participants will complete questionnaires independently at home two and four weeks after the first appointment. A phone call from the doctor will take place three weeks after the initial visit to check on how participants are feeling. Participants will also keep a diary of symptoms, medical consultations, and any medication changes. Throughout the study, researchers will collect and compare scores from EMOCARE and various questionnaires at multiple time points, including baseline, two, four, and six weeks. They will monitor the acceptability of the device, adverse events, and changes in depression severity. The main outcomes measured are changes in EMOCARE scores and PHQ-9 scores from baseline to six weeks. The total participation duration is six weeks, with regular monitoring and assessments to understand emotional states and device use.

Age: 18Years +All GendersPhase Not Applicable
11 locations
U

Actively Recruiting

Researchers are exploring the lived experiences of individuals aged 15 to 30 who are at ultra-high risk UHR or experiencing a first episode of psychosis FEP. This qualitative study aims to describe these experiences during participation in a group-based mindfulness intervention and to identify any potential adverse effects of this type of intervention. The study is sponsored by the Centre Psychothrapique de Nancy and focuses on understanding the impact of mindfulness on social functioning and psychosis risk. Participants take part in a group mindfulness-based program, after which they undergo a qualitative interview. The interview is analyzed using the IPSE Inductive Process to analyze the Structure of lived Experience method to capture detailed personal experiences related to the intervention. The interview occurs between one week and three months following the final mindfulness session. During the study, researchers assess participants social functioning and their experiences with the mindfulness program through these interviews. The primary outcome is the detailed description of participants lived experiences obtained via qualitative interviews. The total duration of involvement varies depending on when the interview takes place after the mindfulness program concludes, with no additional treatments or follow-up mentioned.

Age: 15Years - 30YearsAll GendersPhase Not Applicable
2 locations
E

Actively Recruiting

People with mental disorders tend to smoke more than the general population, which contributes to a significant reduction in their life expectancy, mainly due to cardiovascular and respiratory diseases like bronchial cancers. Smoking cessation efforts targeting this group, especially in psychiatric care, are often insufficient. This study evaluates a new intervention called Tabapsy, designed in collaboration with mental health users, professionals, and general practitioners, aimed at helping adults receiving outpatient psychiatric care reduce or quit smoking. The Tabapsy intervention includes a campaign promoting smoking cessation within psychiatric medical psychological centers CMPs and a structured program to support quitting. This program involves a general information meeting to encourage motivation, an assessment workshop to personalize cessation plans based on nicotine dependence, five thematic workshops addressing treatments, emotional management, weight gain, physical activities, and manual occupations, plus peer support groups to foster mutual aid. A facilitator leads these workshops, and a website complements the resources provided. The trial compares this intervention against usual smoking cessation practices in randomized psychiatric sectors. Participants who regularly smoke and agree to join will complete questionnaires at the start, 3 months, and 6 months, assessing tobacco use, dependence, motivation, well-being, knowledge, and satisfaction. The study will measure short-term smoking cessation at 3 months as the primary outcome, along with various secondary outcomes including motivation, quit attempts, mental and physical well-being, cost-effectiveness, and implementation success. The trial plans to include 6,250 participants over 12 months and will combine quantitative and qualitative evaluations.

Age: 18Years +All GendersPhase Not Applicable
22 locations
S

Actively Recruiting

Healthy Volunteer

Researchers are studying language disorders in people with psychosis, including those at risk, experiencing a first episode, or diagnosed with schizophrenia. The study aims to understand how language difficulties affect communication and relate to thought disorders and neuropsychological symptoms. It also explores interactions between working memory and syntax abilities in these patients. The research compares patients language skills with those of healthy volunteers without mental or language disorders. Participants are divided into groups those with early psychotic symptoms ARMS and FEP, patients with schizophrenia, and healthy controls. Each group undergoes language assessments evaluating various language domains such as phonology, semantics, and pragmatics. Schizophrenia patients additionally complete the TLC scale, while all participants complete the Cannabis Abuse Screening Test CAST. Healthy controls also complete a psychiatric screening using the MINI. During the study, participants undergo comprehensive evaluations including language tests, psychiatric interviews, and neuropsychological assessments. Researchers measure language assessment performance, severity of speech disorganization, thought disorder symptoms, and working memory capacities. Data from medical records are analyzed for associations between language skills and psychiatric symptoms. The study enrollment includes participants aged 16 to 55 years and involves one day of assessments.

Age: 16Years - 55YearsAll GendersPhase Not Applicable
1 location